HERTFORDSHIRE, England & PITTSBURGH & NEW YORK--(BUSINESS WIRE)--Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s ...

Getting a merger done during a pandemic isn’t easy. So in April of last year, Mylan promoted its longtime heavy hitter, controversial Robert Coury, to get it done. Seven months later, Mylan’s merger ...

With the combination of Mylan and Pfizer's Upjohn business complete, the new company, Viatris, has launched. Viatris said that by combining the two companies, it possesses the scientific, ...

Mylan NV is now part of a larger global company with a new name. The generic and specialty pharmaceuticals firm has partnered with Upjohn to form Viatris, which began operations Monday. That was 16 ...

From Nov. 17, Viatris will be the surviving company formed by the combination of leading generic maker Mylan and Upjohn, Pfizer's generics business. The new entity will continue to focus on the prior ...

Pfizer's revenue growth will improve once the Upjohn-Mylan merger wraps up. The big drugmaker will receive a nice $12 billion cash windfall from the deal. Pfizer shareholders will still receive a ...

Calling the tie "magic," Pfizer Inc. CEO Albert Bourla defended his firm's decision to spin off its Upjohn unit and merge in an all-stock deal with Mylan N.V., creating a new entity to be named later ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. DISCLOSURE ...

HERTFORDSHIRE, England, PITTSBURGH and NEW YORK, Sept. 15, 2020 /PRNewswire/ -- Mylan (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the ...